Literature DB >> 12807620

Pulmonary vest therapy in pediatric long-term care.

Audrius V Plioplys1, Shelley Lewis, Irene Kasnicka.   

Abstract

OBJECTIVES: Pulmonary infections are common in children with quadriplegic cerebral palsy. High frequency chest wall oscillation with the vest therapy (VT) is used to promote pulmonary clearance and to prevent pneumonias in cystic fibrosis patients. The purpose of this study was to ascertain the effectiveness of VT in patients with quadriplegic cerebral palsy who reside in pediatric skilled nursing facilities.
METHODS: Seven individuals with quadriplegic cerebral palsy, who had frequent pulmonary infections were identified (age range: 7-28 years; median 19 years; 2 females and 5 males). Five had a tracheostomy and three an active seizure disorder. Clinical data was collected for 12 months before starting VT and during 12 months of VT.
RESULTS: The total number of pneumonias that required antibiotics decreased from 36 per year before VT, to 18 during the year of VT (P < 0.05). The number of hospitalizations due to pneumonia decreased from 9 to 3. With VT, the frequency of effective suctioning of pulmonary secretions was significantly increased (P < 0.01). In the patients with epilepsy, with VT, the average monthly frequency of seizures decreased from 4 to 1, from 9 to 2, and from 9 to 1.
CONCLUSION: VT resulted in more effective suctioning of pulmonary secretions, reduced incidence of pneumonia, and reduced number of hospitalizations for pneumonia. In patients with epilepsy, VT resulted in reduced seizure frequency. VT was tolerated well, without complications or side effects. Further clinical investigations of the use of VT in cerebral palsy are indicated.

Entities:  

Year:  2002        PMID: 12807620     DOI: 10.1097/01.JAM.0000028225.84012.3B

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  8 in total

Review 1.  Non-pharmaceutical management of respiratory morbidity in children with severe global developmental delay.

Authors:  Naomi R Winfield; Nicola J Barker; Esme R Turner; Gemma L Quin
Journal:  Cochrane Database Syst Rev       Date:  2014-10-19

2.  Effects of changes in lung volume on oscillatory flow rate during high-frequency chest wall oscillation.

Authors:  Scott J Butcher; Michal P Pasiorowski; Richard L Jones
Journal:  Can Respir J       Date:  2007-04       Impact factor: 2.409

3.  Airway Clearance Management with Vaküm Technology in Subjects with Ineffective Cough: A Pilot Study on the Efficacy, Acceptability Evaluation, and Perception in Children with Cerebral Palsy.

Authors:  Luca Bertelli; Giulia Bardasi; Salvatore Cazzato; Emanuela Di Palmo; Marcella Gallucci; Giampaolo Ricci; Andrea Pession
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-03-22       Impact factor: 1.349

Review 4.  Airway-Clearance Techniques in Children and Adolescents with Chronic Suppurative Lung Disease and Bronchiectasis.

Authors:  Annemarie L Lee; Brenda M Button; Esta-Lee Tannenbaum
Journal:  Front Pediatr       Date:  2017-01-24       Impact factor: 3.418

5.  Instantaneous responses to high-frequency chest wall oscillation in patients with acute pneumonic respiratory failure receiving mechanical ventilation: A randomized controlled study.

Authors:  Ming-Lung Chuang; Yi-Ling Chou; Chai-Yuan Lee; Shih-Feng Huang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 6.  Respiratory illness in children with disability: a serious problem?

Authors:  Marijke Proesmans
Journal:  Breathe (Sheff)       Date:  2016-12

7.  Management of bronchial secretions with Free Aspire in children with cerebral palsy: impact on clinical outcomes and healthcare resources.

Authors:  Giancarlo Garuti; Elisa Verucchi; Isabella Fanelli; Michele Giovannini; Joao Carlos Winck; Mirco Lusuardi
Journal:  Ital J Pediatr       Date:  2016-01-20       Impact factor: 2.638

8.  Prevention and management of respiratory disease in young people with cerebral palsy: consensus statement.

Authors:  Noula Gibson; Amanda M Blackmore; Anne B Chang; Monica S Cooper; Adam Jaffe; Wee-Ren Kong; Katherine Langdon; Lisa Moshovis; Karolina Pavleski; Andrew C Wilson
Journal:  Dev Med Child Neurol       Date:  2020-08-09       Impact factor: 5.449

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.